Literature DB >> 20686090

Low frequency of CXCR4-using viruses in patients at the time of primary non-subtype-B HIV-1 infection.

Pierre Frange1, Marie-Laure Chaix, Stéphanie Raymond, Julie Galimand, Christiane Deveau, Laurence Meyer, Cécile Goujard, Christine Rouzioux, Jacques Izopet.   

Abstract

We used genotypic and phenotypic assays to estimate the frequency of X4/DM viruses in 131 patients infected with non-subtype-B viruses at the time of primary HIV-1 infection (PHI). All patients were enrolled in the French PRIMO Cohort from 1996 to 2007. Most strains belonged to CRF02_AG (51.1%) and subtype A (14.5%). Sixteen viruses (12.2%) were classified as CXCR4 tropic ("X4 strains") by the combined criteria of amino acids 11 and 25 of the V3 loop (11/25) and net charge rules and/or the SVMgeno2pheno(10%) algorithm: 6 strains by the combined genotypic rule, 7 by the SVMgeno2pheno(10%) algorithm, and 3, clustering in subtype D, by both algorithms. However, only one strain (0.8%), belonging to subtype A, was defined as a dual-tropic (DM) virus by the phenotypic assay. The 67 CRF02_AG strains included 2 classified as X4 strains by the combined genotypic rule (3%) and 2 others classified as X4 strains by SVMgeno2pheno(10%) (3%), but none of these 4 strains was an X4 or DM strain according to the phenotypic assay. These results suggest that the cellular virus reservoir was established with X4 strains in very few non-subtype-B-infected patients at the time of PHI. Genotypic predictions can overestimate the proportion of non-subtype-B X4 viruses at PHI.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686090      PMCID: PMC2953081          DOI: 10.1128/JCM.00704-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  47 in total

1.  Mucosal gatekeepers: selecting HIV viruses for early infection.

Authors:  Morgane Bomsel; Violaine David
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

2.  Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution.

Authors:  J J De Jong; A De Ronde; W Keulen; M Tersmette; J Goudsmit
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection.

Authors:  Eric Delwart; Magdalena Magierowska; Maya Royz; Brian Foley; Lorraine Peddada; Richard Smith; Charles Heldebrant; Andrew Conrad; Michael Busch
Journal:  AIDS       Date:  2002-01-25       Impact factor: 4.177

4.  Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule.

Authors:  R A Fouchier; M Groenink; N A Kootstra; M Tersmette; H G Huisman; F Miedema; H Schuitemaker
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

5.  Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study.

Authors:  J J Maas; S J Gange; H Schuitemaker; R A Coutinho; R van Leeuwen; J B Margolick
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

6.  Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes.

Authors:  E L Delwart; E G Shpaer; J Louwagie; F E McCutchan; M Grez; H Rübsamen-Waigmann; J I Mullins
Journal:  Science       Date:  1993-11-19       Impact factor: 47.728

Review 7.  The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection.

Authors:  John P Moore; Scott G Kitchen; Pavel Pugach; Jerome A Zack
Journal:  AIDS Res Hum Retroviruses       Date:  2004-01       Impact factor: 2.205

8.  Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.

Authors:  M Koot; I P Keet; A H Vos; R E de Goede; M T Roos; R A Coutinho; F Miedema; P T Schellekens; M Tersmette
Journal:  Ann Intern Med       Date:  1993-05-01       Impact factor: 25.391

9.  Genotypic and phenotypic characterization of HIV-1 patients with primary infection.

Authors:  T Zhu; H Mo; N Wang; D S Nam; Y Cao; R A Koup; D D Ho
Journal:  Science       Date:  1993-08-27       Impact factor: 47.728

10.  HIV-1 tropism and survival in vertically infected Ugandan infants.

Authors:  Jessica D Church; Wei Huang; Anthony Mwatha; Jonathan Toma; Eric Stawiski; Deborah Donnell; Laura A Guay; Francis Mmiro; Philippa Musoke; J Brooks Jackson; Neil Parkin; Susan H Eshleman
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

View more
  9 in total

1.  Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.

Authors:  Muhammad Shoaib Arif; James Hunter; Ana Rachel Léda; Jean Paulo Lopes Zukurov; Sadia Samer; Michelle Camargo; Juliana Galinskas; Esper Georges Kallás; Shirley Vasconcelos Komninakis; Luiz Mario Janini; Maria Cecilia Sucupira; Ricardo Sobhie Diaz
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

2.  Relevance of early detection of HIV type 1 SI/CXCR4-using viruses in vertically infected children.

Authors:  Cintia M Crudeli; Paula C Aulicino; Carlos A Rocco; Rosa Bologna; Andrea Mangano; Luisa Sen
Journal:  AIDS Res Hum Retroviruses       Date:  2011-12-02       Impact factor: 2.205

3.  Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism.

Authors:  Jan Weber; Ana C Vazquez; Dane Winner; Richard M Gibson; Ariel M Rhea; Justine D Rose; Doug Wylie; Kenneth Henry; Alison Wright; Kevin King; John Archer; Eva Poveda; Vicente Soriano; David L Robertson; Paul D Olivo; Eric J Arts; Miguel E Quiñones-Mateu
Journal:  J Clin Microbiol       Date:  2013-03-13       Impact factor: 5.948

4.  Determination of the high prevalence of Dual/Mixed- or X4-tropism among HIV type 1 CRF01_AE in Hong Kong by genotyping and phenotyping methods.

Authors:  Sabrina Wai-Chi To; Jonathan Hon-Kwan Chen; Ka-Hing Wong; Kenny Chi-Wai Chan; Zhiwei Chen; Wing-Cheong Yam
Journal:  AIDS Res Hum Retroviruses       Date:  2013-05-31       Impact factor: 2.205

Review 5.  Clinical significance of HIV-1 coreceptor usage.

Authors:  Hanneke Schuitemaker; Angélique B van 't Wout; Paolo Lusso
Journal:  J Transl Med       Date:  2011-01-27       Impact factor: 5.531

6.  HIV-1 subtype D infections among Caucasians from Northwestern Poland--phylogenetic and clinical analysis.

Authors:  Miłosz Parczewski; Magdalena Leszczyszyn-Pynka; Dorota Bander; Anna Urbanska; Anna Boroń-Kaczmarska
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

7.  Chemokine co-receptor usage in HIV-1-infected treatment-naïve voluntary counselling and testing clients in Southern Taiwan.

Authors:  Hung-Chin Tsai; Pei-Yun Chou; Shue-Ren Wann; Susan Shin-Jung Lee; Yao-Shen Chen
Journal:  BMJ Open       Date:  2015-04-29       Impact factor: 2.692

8.  Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partner.

Authors:  Pierre Frange; Laurence Meyer; Matthieu Jung; Cecile Goujard; David Zucman; Sylvie Abel; Patrick Hochedez; Marine Gousset; Olivier Gascuel; Christine Rouzioux; Marie-Laure Chaix
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

9.  HIV-1 integrase strand-transfer inhibitor resistance in southern Taiwan.

Authors:  Hung-Chin Tsai; I-Tzu Chen; Kuan-Sheng Wu; Yu-Ting Tseng; Cheng-Len Sy; Jui-Kuang Chen; Shin-Jung Susan Lee; Yao-Shen Chen
Journal:  Oncotarget       Date:  2018-05-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.